Glenwood

Glenwood is a specialty pharmaceutical company that focuses on the commercialization and distribution of niche therapies for rare and chronic conditions. The company is best known for its flagship product, Potaba (potassium aminobenzoate), which is indicated for the treatment of fibrotic skin disorders including Peyronie's disease and scleroderma. Glenwood operates internationally with key offices in the United States and Germany, maintaining a long-standing presence in the dermatology, urology, and rheumatology sectors. The company specializes in providing established medications that address specific unmet needs in patient populations with inflammatory and fibrotic diseases.